Clinical Trials Directory

Trials / Completed

CompletedNCT05826210

Effect of Sarcopenic Obesity on Weight Loss Outcomes and Quality of Life After Laparoscopic Sleeve Gastrectomy

Status
Completed
Phase
Study type
Observational
Enrollment
245 (actual)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the impact of sarcopenic obesity (SO) on weight loss outcomes and improvement of quality of life after laparoscopic sleeve gastrectomy.

Detailed description

Sarcopenic obesity is a state in which a lack of muscle mass and strength coexists with an increase in fat mass, and it may affect the health outcome of people with obesity after laparoscopic sleeve gastrectomy (LSG).No studies have reported differences in weight loss outcomes between patients with SO and those with non-sarcopenic obesity (NSO) after LSG. Therefore, this study aimed to systematically evaluate the differences in weight loss and quality of life (QOL) evaluation between patients with SO and NSO after LSG and provide high-level evidence-based medical evidence for the impact of SO on weight loss in the obese population and refinement of follow-up strategies.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic sleeve gastrectomyLaparoscopic sleeve gastrectomy was performed in all patients with or without SO.

Timeline

Start date
2015-01-01
Primary completion
2022-07-01
Completion
2022-12-31
First posted
2023-04-24
Last updated
2023-04-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05826210. Inclusion in this directory is not an endorsement.